Personalized Medicine Market 2024 Global Industry, Share, In-Depth Qualitative Insights, Revenue Growth by 2031 | Abbott, GE HealthCare., Danaher Corporation (Cepheid, Inc.)

DataM Intelligence has published a new research report on "Personalized Medicine Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/personalized-medicine-market

The Personalized Medicine market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Personalized medicine is a cutting-edge approach in healthcare that tailors treatments based on an individual's genetic profile, lifestyle, and medical history. By leveraging advanced tools, healthcare providers can detect genetic variations or biomarkers associated with specific diseases, enabling more targeted and effective interventions. This evolving field is transforming healthcare by improving treatment precision, reducing costs, and enhancing patient outcomes. For example, genetic testing helps determine the most suitable medications and dosages, minimizing adverse reactions and increasing treatment success.

Key Developments:

In August 2024, Exact Sciences Corp. announced the enrollment of the first patient in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence (RWE) study at Baylor Scott & White Health, Texas' largest not-for-profit health system. This large-scale, multi-site study aims to enroll up to 25,000 patients to evaluate the clinical performance, patient and provider experiences, and psychological impact of MCED testing over five years.

In July 2024, Danaher Corporation, a global leader in science and technology, established two new CLIA and CAP-certified laboratories to accelerate the development of Companion Diagnostics (CDx) and Complementary Diagnostics (CoDx). With instruments in over 30,000 hospitals across 120 countries, Danaher is positioned to speed up the commercialization of personalized treatments worldwide.

Forecast Growth Projected:

The Global Personalized Medicine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Personalized Medicine Market:

Abbott, GE HealthCare., Danaher Corporation (Cepheid, Inc.), ASURAGEN, INC., Exact Sciences Corporation, Illumina, Inc., QIAGEN, Genentech, Inc., Biogen, and IBM

Segment Covered in the Personalized Medicine Market:

By Product Type: Personalized Medicine Therapeutics, Personalized Medical Care

By Application: Oncology, Neurology, Cardiology, Psychiatry, Immunology, Others

By End-User: Hospitals & Specialty Care, Diagnostic Centers, Research & Academic Institutes, Others

Regional Analysis:

The global Personalized Medicine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/personalized-medicine-market

Regional Analysis:

The global Personalized Medicine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Personalized Medicine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Personalized Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Personalized Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/personalized-medicine-market

For Affiliate Market: Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

FAQs

How big is the Personalized Medicine Market?

The Personalized Medicine Market size was USD 538.25 Billion in 2023. It is expected to reach USD 976.30 Billion in 2031.

How fast is the Personalized Medicine Market growing?

The Personalized Medicine Market will exhibit a CAGR of 7.8% during the forecast period, 2024-2031.

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.